TACALYX

Tacalyx, a spin-off from Max-Planck-Institute of Colloids and Interfaces, Potsdam/Germany (MPICI), focuses on Tumor-Associated Carbohydrate Antigens (TACAs) as novel target class for cancer treatment. The highly tumor-specific expression of TACAs results from aberrant glycosylation and promotes metastasis, angiogenesis and suppression of the immune system. Tacalyx uses the sophisticated technology of carbohydrate synthesis to synthesize highly pure TACA structures for the generation and identification of antibodies that will be developed into novel therapeutics for the treatment of cancer.

#SimilarOrganizations #People #Financial #Website #More

TACALYX

Industry:

Biotechnology Health Care Life Science Therapeutics

Founded:

2019-01-01

Address:

Berlin, Berlin, Germany

Country:

Germany

Website Url:

http://www.tacalyx.com

Total Employee:

Status:

Active

Contact:

+49 30 407 237 10

Email Addresses:

[email protected]

Total Funding:

7 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Apache Euro Microsoft Exchange Online Office 365 Mail IPv6

Similar Organizations

allinky-biopharma-logo

Current Advisors List

sebastian-pünzeler_image

Sebastian Pünzeler Board Of Director @ Tacalyx
Board_member

detlev-mennerich_image

Detlev Mennerich Board Of Director @ Tacalyx
Board_member

karlheinz-schmelig_image

Karlheinz Schmelig Board Of Director @ Tacalyx
Board_member

lena-krzyzak_image

Lena Krzyzak Board Observer @ Tacalyx
Board_member
2019-07-01

not_available_image

Ulrich Mahr Board Of Director @ Tacalyx
Board_member

peter-neubeck_image

Peter Neubeck Board Of Director @ Tacalyx
Board_member

Current Employees Featured

peter-sondermann_image

Peter Sondermann
Peter Sondermann CEO @ Tacalyx
CEO
2019-07-01

Founder

peter-sondermann_image

Peter Sondermann

Investors List

kurma-life-science-partners_image

Official Site Inspections

http://www.tacalyx.com

Host Informations
Whois Informations

Loading ...